Valeant Pharmaceuticals International Inc (NYSE:VRX)

145.37
Data as of Nov 21
 +2.69 / +1.89%
Today’s Change
105.17
Today|||52-Week Range
153.10
+23.82%
Year-to-Date
Frontrunning: November 5
Nov 23 / Investing Channel
U.S. Markets Recover From Early-Day Losses As Japan's Economy Contracts
Nov 17 / Benzinga
George Soros Just Bought These 3 Stocks: Should You?
Nov 23 / MotleyFool.com
Today's Unusual Social Activity Stock: Valeant Pharmaceuticals International (VRX)
Nov 17 / TheStreet.com
Shire to Relocate Employees Under One Shire Program - Analyst Blog
Nov 20 / Zacks.com
Congratulations, David Pyott
Nov 17 / TheStreet.com
Synergy Pharmaceuticals Drug Fares Well in Phase II Study - Analyst Blog
Nov 20 / Zacks.com
Allergan's $66 Billion Actavis Deal is Still a Win for Bill Ackman
Nov 17 / TheStreet.com
Zoetis Provides 2015 Earnings Guidance Below Estimates - Analyst Blog
Nov 19 / Zacks.com
Botox maker bought for $66 billion in biggest deal of 2014
Nov 17 / CNNMoney.com
Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews
Nov 19 / Zacks.com
#PreMarket Primer: Monday, November 17: Japan's Economy Unexpectedly Slips
Nov 17 / Benzinga
Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
Nov 19 / Zacks.com
Actavis Rumored to be Close to Acquiring Allergan - Analyst Blog
Nov 17 / Zacks.com
Benzinga's M&A Chatter for Tuesday November 18, 2014
Nov 18 / Benzinga
Frontrunning: November 17
Nov 17 / Investing Channel
Zoetis to Buy Abbott's Animal Health Assets for $255 Million - Analyst Blog
Nov 18 / Zacks.com
Stocks: Six things to know before the open
Nov 17 / CNNMoney.com
Bill Ackman Says He Supports The Allergan-Actavis Deal And CEO Brent Saunders
Nov 18 / Benzinga
Top Trade Ideas For The Week Of November 17, 2014: The Rest
Nov 16 / StockTwits
Ackman Pledges Support For Actavis Bid On Allergan
Nov 18 / Benzinga
Merck KGaA Q3 Earnings Rise Y/Y, 2014 View Upgraded - Analyst Blog
Nov 14 / Zacks.com
Actavis Strikes $66 Billion Deal for Botox Maker Allergan - Analyst Blog
Nov 18 / Zacks.com
Will Actavis Snatch Allergan, Valeant Settle for Zoetis? - Analyst Blog
Nov 13 / Zacks.com
Pharma ETFs in Focus on Allergan Takeover Deal - ETF News And Commentary
Nov 18 / Zacks.com
Bill Ackman's Latest Target: Zoetis Inc.
Nov 12 / MotleyFool.com
Is Bill Ackman Back?
Nov 18 / Benzinga
Bill Ackman vs. Allergan, Inc.: Who Will Win the War of Words?
Nov 11 / MotleyFool.com
Cramer: Zoetis Defends Against Takeover; GoPro Is Going Higher
Nov 18 / TheStreet.com
Salix Crashes on Inventory Issues, Lowered Outlook - Analyst Blog
Nov 10 / Zacks.com
#PreMarket Primer: Tuesday, November 18: Abe To Delay Sales Tax Increase In Japan
Nov 18 / Benzinga
 

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.